ジェノタイピング（遺伝子型判定）の世界市場：ポリメラーゼ連鎖反応（PCR）、DNAシークエンシング、マイクロアレイ、キャピラリー電気泳動...市場調査レポートについてご紹介

1 Introduction (Page No. – 13)
1.1 Market Scope
1.1.1 Markets Covered
1.1.2 Years Considered for the Study
1.2 Currency & Pricing
1.3 Limitations
1.4 Stakeholders

2 Research Methodology (Page No. – 14)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 15)

4 Premium Insights (Page No. – 16)
4.1 Growth Potential of the Genotyping Market
4.2 Genotyping Market in the Asia-Pacific Region
4.3 Genotyping Market: Geographic Growth Opportunities
4.4 Geographic Mix: Genotyping Market, By Technology
4.5 Genotyping Market, By Application & Geography
4.6 Genotyping Market, By Geography

5 Market Overview (Page No. – 17)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Genotyping Market, By Product
5.2.2 Genotyping Market, By Technology
5.2.3 Genotyping Market, By Application
5.2.4 Genotyping Market, By End-User
5.3 Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Advances in Technologies & Decreasing Prices of Dna Sequencing
5.3.1.2 Increasing Incidences and Awareness of Genetic Diseases and Personalized Medicine to Drive the Growth
5.3.1.3 Huge Demand From Emerging Economies With Their Expanding Per Capita Income
5.3.1.4 Growing Importance of Snp Genotyping in the Drug Development Process
5.3.1.5 Increasing Demand for Genome Analysis in Animal and Plant Livestock
5.3.2 Market Restraint
5.3.2.1 Lack of Appropriate Reimbursement Policies
5.3.2.2 Lack of Technical Know-How
5.3.3 Market Opportunity
5.3.3.1 Increasing Access to Healthcare & Growing Investment By Leading Players in Emerging Markets
5.3.3.2 Increasing Demand for Affordable Genotyping Services
5.3.3.3 Increasing Application Areas of Genotyping
5.3.4 Market Challenge
5.3.4.1 Increasing Market Consolidation

6 Industry Insights (Page No. – 21)
6.1 Introduction
6.2 Industry Trends
6.2.1 There is an Increasing Trend in the Pharmacogenomics Study
6.3 Porter’s Five Forces Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Strategic Benchmarking
6.4.1 Players Adopted New Product Launches as A Key Strategy to Increase Their Market Shares

7 Genotyping Market, By Product and Services (Page No. – 23)
7.1 Introduction
7.2 Instruments
7.2.1 Sequencers & Amplifiers
7.2.2 Analyzers
7.3 Reagents & Kits
7.4 Bioinformatics Software
7.5 Genotyping Services

8 Genotyping Market, By Technology (Page No. – 28)
8.1 Introduction
8.2 Microarray
8.3 Capillary Electrophoresis
8.3.1 Restriction Fragment Length Polymorphism (RFLP)
8.3.2 Amplified Fragment Length Polymorphisms (AFLP)
8.3.3 Single Strand Conformation Polymorphism (SSCP)
8.4 Sequencing
8.4.1 Next Generation Sequencing (NGS)
8.4.2 Sanger Sequencing
8.4.3 Pyrosequencing
8.5 Polymerase Chain Reaction (PCR)
8.5.1 Real Time PCR
8.5.2 Digital PCR
8.6 Maldi-Tof
8.7 Others

9 Genotyping Market, By Application (Page No. – 33)
9.1 Introduction
9.2 Pharmacogenomics
9.3 Diagnostic Research
9.4 Animal Genetics
9.5 Agricultural Biotechnology
9.6 Others

10 Genotyping Market, By End-User (Page No. – 39)
10.1 Introduction
10.2 Pharmaceutical & Biopharmaceutical Companies
10.3 Diagnostic & Research Laboratories
10.4 Academic Institutions

11 Genotyping Market, By Region (Page No. – 40)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (ROE)
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. – 46)
12.1 Overview
12.2 Market Share Analysis (2014)
12.3 Key Strategies Adopted By Leading Players
12.4 New Product Launches
12.5 Mergers and Acquisitions
12.6 Agreements, Partnerships, and Collaborations

13 Company Profiles (Page No. – 48)
13.1 Illumina, Inc
13.1.1 Business Overview
13.1.2 Product Portfolio
13.1.3 Key Strategy
13.1.4 Recent Developments
13.2 Affymetrix, Inc
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Key Strategy
13.2.4 Recent Developments
13.3 Life Technologies Corporation (Thermofisher Scientific)
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Key Strategy
13.3.4 Recent Developments
13.4 Agilent Technologies
13.4.1 Business Overview
13.4.2 Product Portfolio
13.4.3 Key Strategy
13.4.4 Recent Developments
13.5 Qiagen NV
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Key Strategy
13.5.4 Recent Developments
13.6 Sequenom Inc.
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Key Strategy
13.6.4 Recent Developments
13.7 Fluidigm Corp.
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Key Strategy
13.7.4 Recent Developments
13.8 Beckman Coulter
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategy
13.8.4 Recent Developments
13.9 Roche
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Key Strategy
13.9.4 Recent Developments
13.10 GE Healthcare
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategy
13.10.4 Recent Developments